Product photograph of the current pack. Each physical unit carries the same blue-teal ZX label artwork, a batch code and a scratch-off verification panel.
Anavar 50
Oxandrolone
- Compound
- Oxandrolone
- Category
- Oral Steroids
- Brand
- Anavar, Var
- Manufacturer
- Zyvex Pharmaceuticals
- Presentation
- 100 tabs
- Strength
- 50 mg/tab
- Route
- Oral
- Storage
- 15–25 °C, protected from light, do not freeze
Batch analysis
Independent batch results for Anavar 50 are not yet published. They will be added here once testing is complete.
Product information
About Anavar 50
50 mg per tablet · 100 tablets · Zyvex Pharmaceuticals
Anavar 50 from Zyvex Pharmaceuticals contains oxandrolone at 50 mg per tablet and comes in a pack of 100 tablets.
This prospect summarises composition, clinical considerations and handling. It supports professional review and does not replace an individual prescription or verified instructions for the exact preparation.
Basic Identification & Composition
Product Name & Active Ingredient
Anavar 50 is the product name used by Zyvex Pharmaceuticals. The ingredient discussed in the following sections is oxandrolone, classified as a anabolic androgenic steroid.
Qualitative & Quantitative Composition
| Property | Details |
|---|---|
| Product name | Anavar 50 |
| Manufacturer | Zyvex Pharmaceuticals |
| Active ingredient | Oxandrolone |
| Strength | 50 mg per tablet |
| Package | 100 tablets |
| Drug class | Anabolic androgenic steroid |
| Chemical formula | C19H30O3 |
| Dosage form and route | Tablet; oral |
Dosage Form
A solid tablet for oral administration. Each tablet provides a measured amount of active ingredient. Confirm suitability with a pharmacist before splitting or crushing; appearance and score lines alone do not establish accurate dose division.
Clinical Particulars
Anavar 50 uses
Anavar 50 from Zyvex Pharmaceuticals contains oxandrolone, an anabolic androgenic steroid. Medical uses of oxandrolone have included supporting weight gain after major surgery, chronic infection or severe trauma, limiting protein breakdown during prolonged corticosteroid treatment, and relieving bone pain associated with osteoporosis. Historical adult treatment schedules used 2.5–20 mg daily in 2–4 divided doses for 2–4 weeks, with further courses determined by clinical response. These are historical medical examples requiring individual prescribing and monitoring.
Outside medical treatment, people use oxandrolone to pursue greater muscle size, strength and a leaner physique. In a 2026 clinic study of 41 women using androgens, 88% reported oxandrolone use; intermittent oral cycles were common, and the principal goals were body composition, muscle size and strength. These reported goals describe why people take it, rather than proving benefit for every user. A general wellbeing benefit or a dosing protocol for improved wellbeing cannot be established from these observations.
Published nonmedical dosing examples vary and do not establish a standard protocol. One bodybuilding case report documented oxandrolone 20 mg daily alongside methandienone 40 mg daily, in repeated periods of three months on and one month off. This is an observed individual pattern, not evidence that the doses or schedule are common or safe: the patient developed a heart attack and subsequent coronary stent thrombosis. Combining drugs also prevents attributing the outcome to oxandrolone alone. Oxandrolone carries liver, cholesterol and hormonal risks; in women, voice deepening and other masculinising effects can persist after stopping.
Dosage and Administration
Historical adult oxandrolone labelling described 2.5–20 mg daily in divided doses. Anavar 50 contains 50 mg per tablet, exceeding the entire upper daily amount in that historical range. It must not be treated as a routine single-tablet dose. A clinician and pharmacist should select an appropriate medicinal strength; the historical regimen is not a current self-treatment recommendation.
Contraindications
Historical contraindications include pregnancy, known or suspected prostate or male breast cancer, female breast cancer with hypercalcaemia, nephrosis or nephrotic nephritis, and hypercalcaemia. Avoid use with allergy to oxandrolone or a tablet ingredient.
Warnings and Precautions
Oxandrolone can cause cholestatic liver injury, peliosis hepatis, liver tumours and harmful cholesterol changes. Liver tests and lipids need monitoring. Fluid retention may worsen cardiac, renal or hepatic disease. Report jaundice, severe abdominal pain or unusual bleeding promptly.
Risks and Interactions
Drug & Food Interactions
Androgens may alter the response to anticoagulants and glucose-lowering medicines. Corticosteroids can add to fluid retention. Review other hormones, supplements and alcohol use with the treating clinician rather than combining them to manage unwanted effects.
Pregnancy and Lactation
Avoid during pregnancy because androgen exposure can affect fetal sexual development. Breastfeeding requires specialist advice. Suppression of gonadotropins can reduce sperm production and fertility; recovery is variable.
Side Effects and Adverse Reactions
Possible class effects include acne, hair changes, altered libido, fluid retention, mood changes, menstrual disturbance and suppression of testicular function. Adverse cholesterol changes and increased haematocrit may be clinically significant. Frequencies cannot be assumed to be the same for all androgens.
Overdose Protocol
For a suspected overdose, contact a poison-information service or urgent medical care and provide the product, amount, time and other substances taken. Collapse, seizures or breathing difficulty require emergency help. Do not induce vomiting or attempt an antidote at home. Clinical treatment depends on symptoms and the substances involved.
Scientific & Technical Data
Pharmacodynamics
Oxandrolone has anabolic and androgenic activity and can suppress the body's own gonadotropin and testosterone production. Its oral activity does not make it free of hepatic or reproductive risks.
Pharmacokinetics
Historical studies reported mean elimination half-lives of approximately 10.4 hours in younger volunteers and 13.3 hours in older subjects. These values are reference pharmacokinetics, not evidence for the dose or bioequivalence of a 50 mg tablet.
Storage and Handling
Keep tablets in their original, tightly closed container, protected from excess heat and moisture and out of the sight and reach of children. Follow the temperature limits and expiry date on the pack. Return expired or unwanted medicines through a pharmacy or medicine take-back programme; do not flush them.
Browse more